About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 4NCT01810224

Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial

This is prospective, randomized, multicenter, multinational, randomized (1:1) study. The aim of this study is to assess the importance of functional assessment of coronary artery disease prior to bypa...

Lead sponsor: Onze Lieve Vrouw Hospital•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Emanuele Barbato, MD, PhD

CONTACT

[email protected]

Sponsors

Lead Sponsor

Onze Lieve Vrouw Hospital

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with stable angina, unstable angina or NSTEMI candidate to CABG
•Significant LAD and/or LM lesion - proved by FFR or Angiography AND
•At least one more, angiographycally intermediate lesion

Exclusion Criteria

•Significant valvular disease with indication to surgical replacement
•Severe left ventricular dysfunction (EF\<35%)
•Acute STEMI
•Atrial fibrillation, if Maze procedure is planned

Related studies

Effect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque

NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT06779630 · Coronary Artery Disease

Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry

NCT07565805 · Coronary Artery Disease (CAD)

RECRUITINGPhase 2

Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction

NCT07560436 · Heart Failure With Preserved Ejection Fraction (HFPEF), Coronary Artery Disease

Strategic Comparison Of Ischemia-based Versus Plaque Burden and vulnErability-based Revascularization in High-Risk Coronary Artery Disease Patients

NCT07324720 · Coronary Artery Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 13, 2013Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE4

Enrollment206

Start dateMar 2013

Last updatedMar 13, 2013

Condition

Coronary Artery Disease

Locations shown

Cardiovascular Center Aalst OLV Hospital

Aalst

Department of Internal Medicine and Cardiology, University Hospital Brno

Brno

Hungarian Institute of Cardiology

Budapest

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 13, 2013Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions